Cardiac radioablation with SBRT is a promising non-invasive modality for refractory ventricular tachycardia that reduces ICD-related events and improves quality of life based on initial reports.
Does cardiac radioablation with SBRT improve outcomes in patients with refractory ventricular tachycardia?
Cardiac radioablation with SBRT is a promising non-invasive modality for refractory VT that warrants further investigation in clinical trials.
Cardiac radioablation with SBRT is a very promising non-invasive modality for the treatment of refractory VT and potentially other cardiac arrhythmias. Initial reports indicate that it is relatively safe and associated with excellent responses, particularly in reduction of ICD-related events, need for anti-arrhythmic medications, and resulting in significantly improved quality of life for patients. Establishment of objective criteria for candidates for cardiac radioablation will accelerate the adoption of this important radiation therapy modality in the treatment of refractory VT and other cardiac arrhythmias in the coming years. In addition, in order to develop more prospective safety and efficacy data, treatment of patients should ideally be performed in the context of clinical trials or prospective registries at, or in collaboration with, experienced centers. Taken together, the future of cardiac radioablation is rich and worthy of further investigation to become a standard treatment in the armamentarium against refractory VT.
Siedow et al. (Mon,) conducted a review in Refractory ventricular tachycardia. Cardiac radioablation with SBRT was evaluated. Cardiac radioablation with SBRT is a promising non-invasive modality for refractory ventricular tachycardia that reduces ICD-related events and improves quality of life based on initial reports.